Refreshing results…
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma
UploadInternational Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
Download from www.nature.comMissing publications? Search for publications with a matching author name.